Shinkichi Takamori

24PUBLICATIONS
37CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Oral and maxillofacial surgeryAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 15, 2026
Impact of Anti-Inflammatory Drug Therapy on the Efficacy of First-Line Atezolizumab Treatment in Patients With Advanced Non-Small Cell Lung Cancer: An Integrated Analysis of Five Randomized Controlled Trials.

|Oct 27, 2025
Prospective validation study of nutritional and immunological predictors in immune checkpoint inhibitor efficacy for non-small cell lung cancer.

Shinkichi Takamori, Mototsugu Shimokawa, Masafumi Yamaguchi

|Oct 14, 2025
Targeting KRAS Inhibitor-Resistant Pancreatic Cancer with an MUC1-C Antibody-Drug Conjugate.

Hiroki Ozawa, Kazuki Takahashi, Tomoki Motegi

|Jan 23, 2025
Survival outcomes of surgery and adjuvant chemotherapy in early-stage small cell and large cell lung cancer: a novel focus on tumors less than 1 cm.

Jorge Raul Vazquez-Urrutia, Junjia Zhu, Shinkichi Takamori

|Sep 27, 2024
Prognostic Implications of Timing of Immunotherapy in Stage IV Non-Small Cell Lung Cancer.

Jorge Raul Vazquez-Urrutia, Max Greenberg, Junjia Zhu

|Jun 27, 2024
The Clinical Role of Adjuvant Chemotherapy after Sublobar Resection for Non-Small-Cell Lung Cancer ≤ 20 mm with Lymph Node Metastases: A Propensity-Matched Analysis of the National Cancer Database.

Shinkichi Takamori, Junjia Zhu, Asato Hashinokuchi

Pageof 4

Frequent Collaborators

5 joint publications

Kazuki Takada

5 joint publications

Takashi Seto

3 joint publications

Mototsugu Shimokawa

3 joint publications

Takefumi Komiya